NeoGenomics (NEO) Tops Q3 EPS by 6c

NeoGenomics (NASDAQ: NEO) reported Q3 EPS of ($0.14), $0.06 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $128.78 million versus the consensus estimate of $122.41 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• BofA lists top 5 themes driving next $1tn in incremental semi sales
• Nike names former Pfizer CFO David Denton as new finance chief